Subject
Neurology (clinical),Neurology,General Medicine
Reference41 articles.
1. Actelion. Oral ponesimod versus teriflunomide in relapsing multiple sclerosis, (2015).
2. The impact of sphinogosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination;Baker;Mult. Scler. Relat. Disord.,2022
3. Fingolimod rebound: a review of the clinical experience and management considerations;Barry;Neurol. Ther.,2019
4. The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs;Bebo;Neurology,2022
5. Pregnancy management in multiple sclerosis and other demyelinating diseases;Bove;Continuum,2022